Sentences with phrase «fair price as»

To ensure as fair a price as possible with regards to the base US price of $ 29.99, we've opted to set the UK price at # 17.99 and the European price at $ 20.99.
Markel defines a fair price as one that allows an outside shareholder to earn the same type of return that the business itself earns.
In other words, Medtronic's current price is 15 % above the fair price as calculated by this first method.
The current price is just 1 % below the fair price as calculated by this first method.
In other words, Hasbro's current price is 3 % above the fair price as calculated by this first method.

Not exact matches

Spearheaded by more than two dozen lenders and small business advocacy organizations, including Lending Club, Funding Circle, the Aspen Institute, and the Small Business Majority, the bill requires transparency about pricing and fees, fair treatment of borrowers and responsible underwriting, as well as clear language and easy - to - understand terms.
Today, the company operates an online marketplace that helps farmers lock in fair prices on seeds, fertilizers and other costly «inputs» they use to grow healthy crops, as well as sell their crops to buyers.
Broadcom said on Tuesday it was evaluating its options and that the revised price for NXP was well beyond what Qualcomm has repeatedly characterized as a «full and fair
Actual results, including with respect to our targets and prospects, could differ materially due to a number of factors, including the risk that we may not obtain sufficient orders to achieve our targeted revenues; price competition in key markets; the risk that we or our channel partners are not able to develop and expand customer bases and accurately anticipate demand from end customers, which can result in increased inventory and reduced orders as we experience wide fluctuations in supply and demand; the risk that our commercial Lighting Products results will continue to suffer if new issues arise regarding issues related to product quality for this business; the risk that we may experience production difficulties that preclude us from shipping sufficient quantities to meet customer orders or that result in higher production costs and lower margins; our ability to lower costs; the risk that our results will suffer if we are unable to balance fluctuations in customer demand and capacity, including bringing on additional capacity on a timely basis to meet customer demand; the risk that longer manufacturing lead times may cause customers to fulfill their orders with a competitor's products instead; the risk that the economic and political uncertainty caused by the proposed tariffs by the United States on Chinese goods, and any corresponding Chinese tariffs in response, may negatively impact demand for our products; product mix; risks associated with the ramp - up of production of our new products, and our entry into new business channels different from those in which we have historically operated; the risk that customers do not maintain their favorable perception of our brand and products, resulting in lower demand for our products; the risk that our products fail to perform or fail to meet customer requirements or expectations, resulting in significant additional costs, including costs associated with warranty returns or the potential recall of our products; ongoing uncertainty in global economic conditions, infrastructure development or customer demand that could negatively affect product demand, collectability of receivables and other related matters as consumers and businesses may defer purchases or payments, or default on payments; risks resulting from the concentration of our business among few customers, including the risk that customers may reduce or cancel orders or fail to honor purchase commitments; the risk that we are not able to enter into acceptable contractual arrangements with the significant customers of the acquired Infineon RF Power business or otherwise not fully realize anticipated benefits of the transaction; the risk that retail customers may alter promotional pricing, increase promotion of a competitor's products over our products or reduce their inventory levels, all of which could negatively affect product demand; the risk that our investments may experience periods of significant stock price volatility causing us to recognize fair value losses on our investment; the risk posed by managing an increasingly complex supply chain that has the ability to supply a sufficient quantity of raw materials, subsystems and finished products with the required specifications and quality; the risk we may be required to record a significant charge to earnings if our goodwill or amortizable assets become impaired; risks relating to confidential information theft or misuse, including through cyber-attacks or cyber intrusion; our ability to complete development and commercialization of products under development, such as our pipeline of Wolfspeed products, improved LED chips, LED components, and LED lighting products risks related to our multi-year warranty periods for LED lighting products; risks associated with acquisitions, divestitures, joint ventures or investments generally; the rapid development of new technology and competing products that may impair demand or render our products obsolete; the potential lack of customer acceptance for our products; risks associated with ongoing litigation; and other factors discussed in our filings with the Securities and Exchange Commission (SEC), including our report on Form 10 - K for the fiscal year ended June 25, 2017, and subsequent reports filed with the SEC.
As companies in one industry after another are discovering, a good product at a fair price, backed up by a responsive customer - service department, is merely the price of admission to the new competitive marketplace.
To be fair, medical inflation is higher than general inflation, and biopharma companies have the unenviable task of explaining that a gross list price increase isn't the same thing as the net they'll take away from that increase after haggling with insurers and pharmacy benefits managers.
The majority think the price is now fair, and almost as many subscribers think it is too high than think it is too low.
While they aren't as good as a wonderful business bought at a fair price, it's still an important lesson.
The acquisition of ChoiceVendor has been accounted for as a purchase of an asset and, accordingly, the total purchase price has been allocated to the tangible and identifiable intangible assets acquired and the liabilities assumed based on their respective fair values on the acquisition date.
The acquisition of mSpoke has been accounted for as a purchase of an asset and, accordingly, the total purchase price has been allocated to the identifiable intangible assets acquired and the liabilities assumed based on their respective fair values on the acquisition date.
The difference between the option exercise price and the fair market value of the Shares on the exercise date is treated as an adjustment in computing the optionee's alternative minimum taxable income and may be subject to an alternative minimum tax which is paid if such tax exceeds the regular tax for the year.
A Business Valuator (or anyone valuating your business such as an accountant) will use a variety of business valuation methods to determine a fair price for your business, such as:
The online giant's move to slash prices on everything from organic baby kale to fair - trade bananas on the same day its $ 13.7 billion acquisition of Whole Foods Market Inc. closes showed the «high - velocity decision making» Amazon founder Jeff Bezos claims as his hallmark, and sent shares of Kroger Co., Costco Wholesale Corp. and Wal - Mart Stores Inc. reeling Thursday.
Some of Aspect's deals it has joined as an external investor providing a fair price to existing investors looking to add to their bets; in others such as many of its seed deals, the firm has typically participated alongside a seed funding specialist as a warm - up to a Series A. «The bumper crop of seed investors creates more opportunity for us,» Gouw says.
The aggregate purchase price has been preliminarily allocated to the tangible and intangible assets acquired and liabilities assumed based upon our assessment of their relative fair values as of the acquisition date, with the excess of the purchase price over the fair value of the net assets acquired recorded as goodwill, as follows:
As the price of cryptocurrency varies dramatically across exchanges and throughout the course of a day, it's not immediately clear how «fair market value» would be determined.
The decision has received a good deal of attention from the press and commentators, largely because the Court rejected the use of the transaction price as compelling evidence of fair value, despite several recent Delaware appraisal decisions that have relied heavily or exclusively on the transaction price.
Upon exercise of an ISO, the spread between the fair market value of the shares received and the exercise price will be an item of adjustment for purposes of the alternative minimum tax, unless the participant disposes of the shares in the same tax year as the ISO is exercised.
They failed to forecast the predictable backlash by those unwilling to accept low wages and the loss of factory jobs as a fair price to pay for the benefits of free trade.
With Ting's pay for what you use service, families can use their phones as needed, and then pay a fair price for what they used.
If the optionee disposes of the shares prior to the expiration of the above holding periods, then the optionee will recognize ordinary income in an amount generally measured as the difference between the exercise price and the lower of the fair market value of the shares at the exercise date or the sale price of the shares.
Given the absence of a public trading market of our common stock, and in accordance with the American Institute of Certified Public Accountants Accounting and Valuation Guide, Valuation of Privately - Held Company Equity Securities Issued as Compensation, our board of directors exercised reasonable judgment and considered numerous and subjective factors to determine the best estimate of fair value of our common stock, including independent third - party valuations of our common stock; the prices at which we sold shares of our convertible preferred stock to outside investors in arms - length transactions; the rights, preferences, and privileges of our convertible preferred stock relative to those of our common stock; our operating results, financial position, and capital resources; current business conditions and projections; the lack of marketability of our common stock; the hiring of key personnel and the experience of our management; the introduction of new products; our stage of development and material risks related to our business; the fact that the option grants involve illiquid securities in a private company; the likelihood of achieving a liquidity event, such as an initial public offering or a sale of our company given the prevailing market conditions and the nature and history of our business; industry trends and competitive environment; trends in consumer spending, including consumer confidence; and overall economic indicators, including gross domestic product, employment, inflation and interest rates, and the general economic outlook.
Each non-employee director who, as of the date of this offering, is serving on our board of directors and is expected to continue his or her service following this offering will be granted an option to purchase shares of our Class A common stock with a grant date fair value of $ 50,000 (or, if such director is unaffiliated with any significant stockholder of the Company, $ 75,000) on the date the shares subject to this offering are priced.
On the date the shares subject to this offering are priced, each non-employee director who, as of the date of this offering, is serving on our board of directors and is expected to continue his or her service following this offering will be granted (a) an option to purchase shares of our Class A common stock with a grant date fair value of $ 50,000 (or, if such director is unaffiliated with any significant stockholder of the Company, $ 75,000) and (b) to the extent such director is (i) unaffiliated with any significant stockholder of the Company and (ii) the chairman of any committee of our board of directors, an additional option to purchase shares of our Class A common stock with a fair value of $ 10,000 with respect to each such chairmanship.
Under the terms of our equity incentive plans, the fair market value on the grant date is defined as the average of the high and low trading prices of FedEx's stock on the New York Stock Exchange on that day.
The purchase price has been allocated to the tangible and intangible assets acquired and liabilities assumed based upon our assessment of their relative fair values as of the acquisition date, with the excess of the purchase price over the fair value of the net assets acquired recorded as goodwill, as follows:
The tender offer closed in September 2011, and at the close of the transaction, the Company recorded $ 34.7 million as compensation expense related to the excess of the selling price per share of common stock paid to the Company's employees and consultants over the fair value of the tendered share, and $ 35.8 million as deemed dividends in relation to excess of the selling price per share of common and preferred stock paid to existing investors in excess of the fair value of the shares tendered.
The additional factors considered when determining any changes in fair value between the most recent valuation report and the grant dates included, when available, the prices paid in recent transactions involving our equity securities, as well as our operating and financial performance, current industry conditions and the market performance of comparable publicly traded companies.
Pursuant to ASC 805 - 10, under the acquisition method, the total estimated purchase price (consideration transferred) as described in Note 3, Preliminary Purchase Price Allocation, is measured at the acquisition closing date using the fair value of the Company's common stock on that price (consideration transferred) as described in Note 3, Preliminary Purchase Price Allocation, is measured at the acquisition closing date using the fair value of the Company's common stock on that Price Allocation, is measured at the acquisition closing date using the fair value of the Company's common stock on that date.
The purchase price was allocated to the tangible and intangible assets acquired and liabilities assumed based upon management's assessment of their relative fair values as of the acquisition date with $ 33,612 attributed to goodwill, $ 10,800 to identified intangible assets and $ 112 of net liabilities assumed.
terminate either (a) each outstanding option or (b) each outstanding option that is fully exercisable as of the date of such transaction, in exchange for a cash payment equal in amount to the excess, if any, of the fair market value, as determined by our board of directors, of a share of our common stock over the per - share exercise price of each such option, multiplied by the number of shares subject to each such option.
The purchase price per share in the tender offer represented an excess to the fair value of the Company's outstanding common stock and Series A through Series F convertible preferred stock, as determined by the Company's most recent valuation of its capital stock at time of the transaction.
The aggregate purchase price has been allocated to the tangible and intangible assets acquired and liabilities assumed based upon our assessment of their relative fair values as of the acquisition date, with the excess of the purchase price over the fair value of the net assets acquired recorded as goodwill, as follows:
This transaction was accounted for as a purchase of assets and, accordingly, the total purchase price was allocated to the identifiable intangible assets acquired based on their respective fair values on the acquisition date.
The diluted net income (loss) per share calculations include shares of Class A, Class A-1, and Class B common stock, as well as warrants to purchase shares of Class A and Class C common stock where the warrant exercise price is below the fair value of the underlying common stock and therefore would have a dilutive effect.
Still, as Warren Buffett once wrote, «It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price
As Warren Buffett said, «It's far better to buy a wonderful company at a fair price than a fair company at a wonderful price
As the key discount rate for equity prices, this has had a material effect on «fair value» for stock prices.
But where my long term account is concerned, I really have no interest to sell, bear market or bull market, so long as the business is fine and the price is fair Just wanted to explain some of my recent purchases, and why the long - term view requires a different approach.
Keeping Warren Buffett's advice «it is far better to buy a wonderful company at a fair price than a fair company at a wonderful price» in mind, I zeroed in on Dominion Resources (Symbol: D) as the utility company to purchase.
But where my long term account is concerned, I really have no interest to sell, bear market or bull market, so long as the business is fine and the price is fair
Stocks of an outstanding company such as Roche acquired at a fair price can still deliver very decent returns over time.
I consider anything within 10 % of fair value to be fairly valued, so I would label the current price as Ffair value to be fairly valued, so I would label the current price as FairFair.
When we get to one - half fair value, the likely 10 - year annualized return is 15 percent real (just as the long - term return is horrible when stocks are priced as they were before the crash, it is amazing when they are priced super-low).
As long - term shareholders, we have developed great respect for the members of Heinz's management team, and they didn't disappoint us when they had the opportunity to sell the business for a fair price.
a b c d e f g h i j k l m n o p q r s t u v w x y z